2型糖尿病模型GK大鼠骨形态学和生物力学特点观察

被引:2
作者
张丽萍
荣海钦
季虹
刘亚平
赵新波
邱占军
王东
机构
[1] 山东省内分泌与代谢病研究所
关键词
骨密度; 骨生物力学; 骨组织形态计量学; 骨丢失; 2型糖尿病; GK大鼠;
D O I
暂无
中图分类号
R587.2 [糖尿病性昏迷及其他并发症]; R318.01 [生物力学];
学科分类号
1002 ; 100201 ; 0831 ;
摘要
目的观察2型糖尿病模型GK大鼠的骨代谢特点以及骨密度和骨生物力学特性的变化。方法采用雄性6月龄GK大鼠10只,以月龄、性别匹配的健康Wistar大鼠作为正常对照。颈静脉取血检测与骨代谢有关的生化指标。DXA法测定股骨和腰椎骨密度,并行股骨三点弯曲实验和腰椎压缩实验。甲基丙烯酸甲酯包埋胫骨干骺端以制备不脱钙骨切片。应用多媒体病理图像分析软件进行骨组织形态计量学分析。结果GK大鼠体重明显低于健康对照Wistar大鼠(P<0.01)。与对照组相比,GK大鼠血清骨钙素水平明显降低[(4.97±0.49,6.75±0.71)μg/mL,P<0.01],而抗酒石酸酸性磷酸酶活性明显升高[(17.92±5.23,8.31±2.69)U/L,P<0.01],但血钙和血磷无明显变化(P>0.05);股骨和腰椎骨密度显著降低[(0.16±0.01,0.22±0.02;0.12±0.01,0.16±0.02)g/cm2,P<0.01];骨强度和腰椎的弹性模量明显降低(P<0.01)。骨形态学分析显示GK大鼠股骨长度和第五腰椎高度分别降低10.3%和9.5%(P<0.01),股骨和腰椎横截面积无明显变化(P>0.05)。骨组织形态计量学分析显示,GK大鼠骨小梁体积、骨小梁厚度、类骨质表面和厚度明显降低[(15.72±1.18,19.13±1.13)%,(61.91±4.54,74.43±3.63)μm,(18.18±1.25,19.63±1.07)%,(3.68±0.48,4.34±0.35)μm,P<0.01或0.05],动态参数如矿化表面、矿化沉积率和骨形成率也明显降低[(17.77±1.54,19.56±2.07)%,(1.07±0.22,1.35±0.16;0.20±0.03,0.26±0.04)μm/day,P<0.05或0.01],而矿化延迟时间显著延长(2.66±0.56,2.12±0.35,P<0.05)。结论非肥胖的GK大鼠表现有骨量减少和骨折危险性增加;2型糖尿病本身可干扰成骨细胞功能和活性而导致骨重建失衡。
引用
收藏
页码:361 / 365
页数:5
相关论文
共 23 条
[1]  
Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm. Portha,B. Diabetes Metabolism Reviews . 2005
[2]  
Non-insulin-dependent diabetes,bone mineral density,and cardiovascularrisk factors. Perez-Castrillon JL,De Luis D,Martin-Escudero JC,et al. Journal of Diabetes and Its Complications . 2004
[3]  
Advanced glycation end products enhance osteoclast-induced bone resorptionincultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. Miyata T,Notoya K,Yoshida K,et al. Journal of the American Society of Nephrology . 1997
[4]   自发的2型糖尿病动物模型 [J].
王芬 ;
何华亮 ;
刘铜华 .
中国实验动物学报, 2007, (05) :395-398
[5]  
Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. Liu R,Bal HS,Desta T,et al. Journal of Dental Research . 2006
[6]  
Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. Botolin S,McCabe LR. Journal of Cellular Biochemistry . 2006
[7]  
Evaluation of bone metabolismand bone massin patients withtype-2diabetes mellitus. Oz SG,Guven GS,Kilicarslan A,et al. Journal of the National Medical Association . 2006
[8]  
Bone mineral density and itsdeterminants in diabetes:the Fremantle Diabetes Study. Rakic V,,Davis WA,Chubb SA,et al. Diabetologia . 2006
[9]  
The effects of quercetin on bone minerals,biomechanical behavior,and structure in streptozotocin-induced diabetic rats. Kanter M,Altan MF,Donmez S,et al. Cell Biochemistry and Function . 2007
[10]  
Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study[J] . V. Rakic,W. A. Davis,S. A. P. Chubb,F. M. A. Islam,R. L. Prince,T. M. E. Davis. &nbspDiabetologia . 2006 (5)